Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
10.64 USD | -3.54% | -5.34% | -50.63% |
21/05 | JPMorgan Adjusts Teladoc Price Target to $16 From $19, Maintains Neutral Rating | MT |
29/04 | Truist Securities Cuts Teladoc's Price Target to $15 From $17, Maintains Hold Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-50.63% | 1.8B | |
+78.57% | 584M | |
+3.54% | 446M | |
-74.51% | 113M | |
-28.06% | 91.45M |
- Stock Market
- Equities
- TDOC Stock
- News Teladoc Health, Inc.
- Teladoc Guides For Q4 EPS Loss of $0.33-$0.23 on Revenue of $658-$683 Million, vs CIQ Analyst Consensus of $0.19/Share Loss on Revenue of $687 Million